These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18589877)

  • 1. FDA reviewing safety of Ziagen and Videx.
    AIDS Read; 2008 May; 18(5):236. PubMed ID: 18589877
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
    AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart attack risk with abacavir and didanosine.
    AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
    [No Abstract]   [Full Text] [Related]  

  • 4. Abacavir and didanosine increase the risk of heart attack.
    AIDS Patient Care STDS; 2008 Mar; 22(3):253-4. PubMed ID: 18348343
    [No Abstract]   [Full Text] [Related]  

  • 5. Abacavir gets green light from FDA advisory board. Food and Drug Administration.
    TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziagen (abacavir) approved: caution essential.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ddI, d4T, Hydroxyurea: new pancreatitis warning.
    AIDS Treat News; 1999 Nov; (No 331):1-3. PubMed ID: 11367125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abacavir update.
    Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double "d" drug danger.
    Moyle G
    AIDS Read; 2003 Jan; 13(1):15-6, 23-4. PubMed ID: 12569891
    [No Abstract]   [Full Text] [Related]  

  • 10. Abacavir, Didanosine: myocardial infarction.
    Prescrire Int; 2008 Dec; 17(98):244. PubMed ID: 19431227
    [No Abstract]   [Full Text] [Related]  

  • 11. Abacavir and increased risk of myocardial infarction.
    Goicoechea M; McCutchan A
    Lancet; 2008 Sep; 372(9641):803-4; author reply 804-5. PubMed ID: 18774413
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended warning on Didanosine-related pancreatitis.
    Res Initiat Treat Action; 1999 Dec; 5(5):22-3. PubMed ID: 11366889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziagen OK'd by FDA.
    Gaylord G
    Posit Living; 1999 Feb; 8(1):1, 11. PubMed ID: 12492045
    [No Abstract]   [Full Text] [Related]  

  • 14. Ziagen clears FDA advisory panel.
    Gaylord G
    Posit Living; 1998 Dec-1999 Jan; 7(12):1, 6, 8. PubMed ID: 12154746
    [No Abstract]   [Full Text] [Related]  

  • 15. EU issues warning about HAART regimen.
    AIDS Patient Care STDS; 2004 Jan; 18(1):56-7. PubMed ID: 15080094
    [No Abstract]   [Full Text] [Related]  

  • 16. Abacavir sulfate (Ziagen).
    Simmons P
    Res Initiat Treat Action; 1999 Apr; 5(2):8-10. PubMed ID: 11366289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir (Ziagen) approval recommended.
    AIDS Treat News; 1998 Nov; (No 306):4. PubMed ID: 11365961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smaller tablet for Videx.
    AIDS Patient Care STDS; 1996 Aug; 10(4):261. PubMed ID: 11361603
    [No Abstract]   [Full Text] [Related]  

  • 19. ddI: FDA approves once-daily dosing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1999 Nov; (No 330):1. PubMed ID: 11367169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA notifications. New labeling for Videx pediatric powder.
    AIDS Alert; 2009 Aug; 24(8):94-6. PubMed ID: 19705588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.